Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial - Ghaneh, P; Palmer, D; Cicconi, S (Lancet Gastroenterol Hepatol, 2023)
et al.